Found: 12
Select item for more details and to access through your institution.
Safety and efficacy of tarenflurbil in subjects with mild Alzheimer's disease: Results from an 18-month international multi-center phase 3 trial
- Published in:
- 2009
- By:
- Publication type:
- Abstract
O3-04-01: Safety and efficacy of tarenflurbil in subjects with mild Alzheimer's disease: Results from an 18-month multi-center phase 3 trial
- Published in:
- 2008
- By:
- Publication type:
- Abstract
P-015: A responder analysis of MPC-7869 (tarenflurbil), a selective Aβ42-lowering agent, in mild Alzheimer’s disease (AD): Analysis from a phase 2 study of up to 24 months of treatment
- Published in:
- 2007
- By:
- Publication type:
- Abstract
P2-412: MPC-7869 (R-flurbiprofen), a selective Aβ42-lowering agent, delays time to clinically significant psychiatric events in Alzheimer’s disease (AD): Analysis from a 12-month phase 2 trial
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P2-411: MPC-7869 (R-flurbiprofen), a selective Ab42-lowering agent, displays no significant CYP2C9 drug-drug interactions: A phase 1 study
- Published in:
- 2006
- By:
- Publication type:
- Abstract
O4-03-08: Efficacy and safety of MPC-7869 (R-flurbiprofen), a selective Aβ42-lowering agent, in Alzheimer’s disease (AD): Results of a 12-month phase 2 trial and 1-year follow-on study
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P2-412: MPC-7869 (R-flurbiprofen), a selective Aβ42-lowering agent, delays time to clinically significant psychiatric events in Alzheimer’s disease (AD): Analysis from a 12-month phase 2 trial
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P2-411: MPC-7869 (R-flurbiprofen), a selective Ab42-lowering agent, displays no significant CYP2C9 drug-drug interactions: A phase 1 study
- Published in:
- 2006
- By:
- Publication type:
- Abstract
O4-03-08: Efficacy and safety of MPC-7869 (R-flurbiprofen), a selective Aβ42-lowering agent, in Alzheimer’s disease (AD): Results of a 12-month phase 2 trial and 1-year follow-on study
- Published in:
- 2006
- By:
- Publication type:
- Abstract
dnaC mutations suppress defects in DNA replication- and recombination-associated functions in priB and priC double mutants in Escherichia coli K-12.
- Published in:
- Molecular Microbiology, 1999, v. 34, n. 1, p. 91, doi. 10.1046/j.1365-2958.1999.01576.x
- By:
- Publication type:
- Article
Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer Disease.
- Published in:
- JAMA: Journal of the American Medical Association, 2009, v. 302, n. 23, p. 2557, doi. 10.1001/jama.2009.1866
- By:
- Publication type:
- Article